Andrew Spaventa - 15 Jun 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 17:04:01 UTC
Previous filing
17 Mar 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +14,583 +149% 24,349 15 Jun 2023 Direct F1
transaction OMIC Common Stock Gift $0 -14,583 -60% $0.000000 9,766 15 Jun 2023 Direct F2
transaction OMIC Common Stock Gift $0 +14,583 +0.37% $0.000000 3,928,154 15 Jun 2023 By The Andrew K. Spaventa Living Trust dated April 9, 2014

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -14,583 -6.2% 218,750 15 Jun 2023 Common Stock 14,583 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.